Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
Variant Bio's Inference platform uses LLM technology, machine learning, and advanced statistical genetics to analyze hundreds of billions of data points, moving from genetic association to validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback